Intrathecal drug spreadT HIS year sees the one hundredth anniversary of the first deliberate spinal (i.e., intrathecal) anaesthetic by August Bier in Kiel in Germany. 1 The subsequent century, since this first direct pharmacological assault on the central nervous system, has seen a number of swings in the popularity of the technique. These swings have been associated with (and perhaps driven by) three common themes. On the negative side have been concerns about the risk of neurological damage and frustration at the variability between patients in the effect of a standard injection. Conversely, increased popularity has often been associated with the availability of a new drug preparation. This is certainly relevant to the current popularity which, to a degree at least, stems from the interest there was in evaluating bupivacaine for this purpose in the early 1980s. 2 Other factors include the challenges produced by changes in surgical practice, particularly in elderly patients, and greater understanding of the causes of complications of all kinds. The recent FDA announcement regarding the possible risk of vertebral canal bleeding in association with the use of the new heparin type drugs shows that concerns about safety remain, although they have been explored by a number of authors, s,4However, the topic of this contribution is the more frequent problem: the causes of variability in effect. The problem was recognised from the beginning, even Bier referring to the "lauenhaft" or waywardness of the technique. Since then there has been a progressive, almost exponential growth of research in this field, but a clear understanding of the mechanism(s) of spread of drugs through the subarachnoid space has remained elusive. The variability between patients relates to both extent and duration of block, and occurs even when technically identical injection techniques are used. The search to identify and control the factors influencing this variability began shortly after Bier's pioneering work. Barker, a London based surgeon, was the first to examine the problem systematically using a glass model of the spinal column as well as clinical observation, s-7 He deduced that gravity and the curves of the vertebral column could be used to influence the spread of a solution with a density which differed from that of cerebrospinal fluid. As a result he devised a solution that was hyperbaric and could be used with predictable effects. Babcock, meanwhile, took the opposite approach using a solution that was less dense than cerebrospinal fluid so that it would "float. ''sSince then a huge amount of information has been generated, allowing Greene to identify, in a major review, 25 factors that affect spread of a solution through the CSF. 9 This is a daunting prospect for the clinician trying to develop a technique, particularly because there are still some unknowns. However, two papers in this issue add some useful information to our knowledge of the CSF and local anaesthetic components of the equation. The latter, at least, is under our ...